Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Curtiss-Wright Corporation (NYSE: CW) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Curtiss-Wright is a global integrated business that supplies highly engineered products, solutions and services mainly to aerospace and defense markets, and critical technologies in commercial nuclear power, process and industrial markets. Its filings offer detailed insight into how these activities translate into financial results, risks and capital allocation decisions.
Through periodic reports such as Form 10-K and Form 10-Q, Curtiss-Wright presents segment information for Aerospace & Industrial, Defense Electronics, and Naval & Power, along with discussions of total aerospace and defense markets and total commercial markets. These documents typically include data on sales, operating income, operating margin, new orders, backlog and free cash flow, as well as commentary on factors such as product mix, restructuring initiatives and operational excellence programs.
Current reports on Form 8-K provide updates on specific events, including quarterly and annual earnings releases, changes to financial guidance, adoption of Rule 10b5-1 trading plans for share repurchases, and expansions of repurchase authorizations. These filings describe how Curtiss-Wright structures its repurchase programs, the amounts authorized, and the expected timing of purchases under those plans.
Stock Titan enhances access to these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand segment performance, capital allocation actions and notable risk disclosures. Real-time updates from EDGAR, along with visibility into relevant forms such as 10-K, 10-Q and 8-K, allow investors and researchers to review Curtiss-Wright’s regulatory history and ongoing reporting in a structured, easy-to-navigate format.
Curtiss-Wright reported record fourth-quarter and full-year 2025 results with strong growth in sales, earnings, and cash flow. For Q4 2025, sales were $947 million, up 15%, and adjusted diluted EPS was $3.79, up 16%. Full-year 2025 sales reached $3.5 billion, up 12%, with adjusted operating income of $651 million, up 19%, and adjusted EPS of $13.23, up 21%. Free cash flow was $554 million, a 15% increase with 111% conversion, while new orders of $4.1 billion and backlog of $4.1 billion each rose 10% and 18%, respectively. The company repurchased $465 million of stock. For 2026, Curtiss-Wright guides to 6%–8% sales growth, adjusted operating margin of 18.9%–19.2%, adjusted EPS of $14.70–$15.15 (up 11%–15%), and free cash flow of $575–$595 million.
Curtiss-Wright director Anthony J. Moraco received an annual equity award of 256 shares of common stock on February 4, 2026. The shares were granted under the company’s 2024 Omnibus Incentive Plan as restricted stock for his service on the board.
The award value was $160,000, calculated using the closing share price of $624.93 on the grant date and rounded down to the nearest whole share. Restrictions lapse after one year or earlier if his board service ends due to death, disability, or failure to be reelected. Following this grant, Moraco directly holds 5,446 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation director Larry D. Wyche reported an equity grant of restricted common stock. On February 4, 2026, he acquired 128 shares of common stock at a reference price of $624.93 per share under the company’s 2024 Omnibus Incentive Plan.
The award represents half of a $160,000 annual restricted stock grant for non-employee directors, with the number of shares determined by dividing the grant value by the closing price and rounding down. Wyche elected to defer receipt of the remaining 128 shares to a later date. Following this transaction, he beneficially owned 1,514 common shares directly. Restrictions on the granted shares generally lapse after one year or earlier upon death, disability, or failure to be reelected.
Curtiss-Wright executive John C. Watts reported routine share transactions in company stock. On February 3, 2026, he acquired 1,354 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
On February 4, 2026, Watts sold 652 shares of common stock at an average price of $625.57 per share, in line with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, he directly owned 3,890 Curtiss-Wright common shares.
Curtiss-Wright senior vice president and treasurer Robert F. Freda reported an equity award vesting and a related share sale. On February 3, 2026, he acquired 784 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group, at a reference price of $674.32 per share.
On February 4, 2026, Freda sold 418 shares of common stock at an average price of $626.95, with individual trades ranging from $611.26 to $658.97. The sale was conducted under company share ownership guidelines to cover income tax obligations from the vesting. After these transactions, he directly held 5,187 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation Executive VP and COO Kevin Rayment reported stock transactions related to a long-term incentive award. On February 3, 2026, he acquired 6,618 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on the company’s three-year total shareholder return versus its peer group, at a reference price of $674.32 per share.
On February 4, 2026, he sold 2,634 shares of common stock, in transactions averaging $626.33 per share, with actual prices ranging from $608.82 to $660.05. The filing states these sales were made in line with the company’s share ownership guidelines, allowing the executive to sell part of the vested shares to cover individual income tax obligations from the award vesting. After these transactions, he directly owned 29,896 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation’s Executive VP and CFO K. Christopher Farkas reported a performance-based stock grant and a related share sale. On February 3, 2026, he acquired 5,770 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, valued using the $674.32 NYSE closing price on the vesting date.
On February 4, 2026, he sold 2,665 shares at an average price of $626.33, with prices ranging from $609.29 to $660.49, to cover individual income tax obligations tied to vesting. After these transactions, he directly owned 7,358 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation’s Chair and CEO Lynn M. Bamford reported equity award vesting and a related share sale. On February 3, 2026, she acquired 20,268 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, based on three-year total shareholder return versus peers, using $674.32 as the NYSE closing price on the vesting date.
On February 4, 2026, she sold 9,327 shares of common stock at an average price of $626.45 per share, with the sale described as complying with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, she directly held 46,192 shares of Curtiss-Wright common stock.
Curtiss-Wright Senior VP & Corp Controller Gary A. Ogilby reported equity award vesting and related share sales. On February 3, 2026, he acquired 1,060 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
Also on February 3, 2026, these shares vested at a reference price of $674.32 per share, the New York Stock Exchange closing price that day. On February 4, 2026, he sold 435 shares at an average price of $626.56, and on February 5, 2026, he sold 625 shares at an average price of $624.32. The filing states that a portion of vested shares was sold in line with company share ownership guidelines to cover income tax obligations, and that the February 5 sale was made under a Rule 10b5-1 trading plan adopted on September 11, 2025.
Following these transactions, Ogilby directly beneficially owned 2,571 shares of Curtiss-Wright common stock.
An insider associated with CW has filed a Rule 144 notice to sell 625 shares of common stock through UBS Financial Services Inc. on or about 02/05/2026 on the NYSE, with an aggregate market value of $385,359.38.
The 625 shares were acquired from the issuer on 02/03/2026 via a performance share unit (PSU) transaction. As context, the filing lists 36,874,638 common shares outstanding and notes a recent sale of 435 shares on 02/04/2026 for gross proceeds of $272,427.46.